BioSpace News Archive

Healthcare IT partner Netsmart announced its recent partnership with hospice and palliative care provider, Capital Caring.

Public-private investment will prepare 8th-12th grade students in rural communities for careers in biomanufacturing of agriculture, medicine, food and beverage products.

Kowa Pharmaceuticals America, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the cholesterol-lowering drug LIVALO® (pitavastatin) for pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (Apo B).

Disease control rate of up to 83% achieved; evidence of improved survival for patients

Company Announces Enrollment Met for 2-5 Year-Old Cohort in Separate Phase 2 Study in Infants and Young Children

Comprehend reveals new solution at DIA 2019, designed for clinical trial process improvement and greater ICH E6(R2) compliance.

Maze Therapeutics, a company focused on translating genetic insights into new medicines, today announced that Jason Coloma, Ph.D., Maze’s current chief operating officer, has been appointed as chief executive officer.

Offers New Therapy for Treating Heart Patients in the Cath Lab

New Detector Designed to Capture Pediatric, Extremity and Tabletop Imaging Exams

Suite of new offerings uses digital innovation to better identify and evaluate evidence for enhanced strategic planning